Summary & Overview
HCPCS G0684: Non-Sheet HCT/P Skin Substitute Graft, Area-Based Add-On
HCPCS Level II code G0684 is an add-on code for reporting the application of a premarket approval (PMA), 510(k), or 361 human cells, tissues, or cellular and tissue-based product (HCT/P) non-sheet form skin substitute graft when the wound surface is greater than or equal to 100 square centimeters. It matters nationally because it captures area-based billing for advanced biologic wound therapies used in complex or large wounds, affecting reimbursement, utilization tracking, and clinical documentation standards across outpatient surgical and wound care settings. Major payers commonly involved in coverage and payment decisions for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context for the code, typical sites of service where it is billed, and the role of G0684 as an add-on area-based reporting code for non-sheet skin substitute grafts. The publication also summarizes available benchmarks, coding practice considerations, and recent policy developments relevant to area-based skin substitute billing. Data not available in the input is noted where specific payer policies, modifiers, taxonomies, ICD-10 pairings, and related codes would normally be detailed.
Billing Code Overview
HCPCS Level II code G0684 describes the application of a premarket approval (PMA), 510(k), 361 human cells, tissues, or cellular and tissue-based product (HCT/P) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm, billed in increments for each additional 100 sq cm or each additional 1% of body area for infants and children. The code is an add-on code for reporting additional grafted wound surface area and is listed separately in addition to the primary procedure.
Service Type: Skin substitute graft application (non-sheet HCT/P), area-based add-on reporting
Typical Site of Service: Hospital outpatient department, ambulatory surgery center, or other outpatient wound care settings
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a chronic, non-healing full-thickness lower extremity wound measuring 150 square centimeters presents to a wound care clinic after failed conservative care including dressings, offloading, and local debridement. The wound has been assessed for infection, vascular status, and glycemic control. After surgical debridement in the outpatient procedure suite under local or monitored anesthesia care, the clinician elects to apply a premarket-approved, 510(k) or PMA human cell- or tissue-based skin substitute in non-sheet form to promote granulation and closure. The index application of the graft is reported with G0684 for the first ≥100 sq cm of wound surface. An additional unit is reported for the remaining area (the additional 50 sq cm) using the same code reported as an add-on per its descriptor.
Typical clinical workflow:
-
Patient evaluation and wound measurement, photography, and documentation of etiology and prior treatments.
-
Pre-procedure optimization (infection control, vascular assessment, glycemic control, consent).
-
Sharp surgical debridement and wound bed preparation in the procedure room or ambulatory surgery center.
-
Application of the non-sheet human cellular/tissue-based skin substitute to the prepared wound surface; secure dressing applied.
-
Post-application instructions, wound care plan, and scheduled follow-up for graft assessment and potential repeat applications.